There are 2949 resources available
Lung cancer diagnostic test needs: perspective from a thoracic oncologist
Presenter: Gabriela Fernandes
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Establishment of a large-scale Asian genomic screening platform to identify non-small cell lung cancer with rare driver oncogenes and clarify drug resistant mechanisms
Presenter: Koichi Goto
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
NTRK, RET and other fusion biomarkers testing: Latest developments
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Welcome and introduction
Presenter: Neal Shore
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Introduction
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Optimizing treatment strategies in first-line mCRC
Presenter: Mark Saunders
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Extending the continuum of care beyond second-line mCRC
Presenter: Timothy Price
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Conclusion
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Panel discussion moderated by Bettina Ryll
Presenter: Deepak Khanna
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Welcome and introductions
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast